PHARMA
Thermo Fisher Scientific Strengthens Presence In South Korea
To address a growing demand for clinical services, Thermo Fisher Scientific has opened a good manufacturing practices standards facility in Seoul, South Korea.
Hong Kong Chemists Synthesize Promising Antibiotic Teixobactin
Scientists in Hong Kong have successfully synthesized teixobactin and ten analogs with promising properties.
ASLAN, A*STAR To Develop Therapeutic Antibody Against RON Kinase
ASLAN Pharmaceuticals will license a therapeutic antibody from A*STAR that targets the macrophage-stimulating protein receptor, also known as Recepteur d’Origine Nantais kinase.
Takeda To Develop Zika Vaccine With $19.8m BARDA Funding
The US$19.8 million initial funding will cover the development of a Zika vaccine through to a Phase I clinical trial.
Wnt Pathway Inhibitor Fights Colorectal Cancer Stem Cells
Researchers have developed a small molecule inhibitor that blocks a signaling pathway essential to cancer stem cell development.
Singlera Genomics Raises $20 Million In Series A Financing
Led by Lilly Asia Ventures, this financing round will go towards the development and commercialization of Singlera's non-invasive genomic sequencing tests.
IBM Watson To Fight Cancer In 21 Hospitals Across China
IBM and Hangzhou CognitiveCare plan to bring the Watson cognitive computing platform to 21 hospitals across China.
Your Gut Bacteria Could Affect How Drugs Work For You
Microorganisms in the gut likely have an effect on how the body metabolizes drugs, according to a new study.
Bristol-Myers Squibb Reacquires Rights To ASLAN Drug
Bristol-Myers Squibb will be reacquiring the rights to ASLAN002, a gastric and breast cancer drug, for several APAC markets.
